Biotechnology news

• Should Biotechnology Stock 89bio Inc (ETNB) Be in Your Portfolio Thursday? - InvestorsObserver

  11-05-2023 21:30 via news.google.com
  Should Biotechnology Stock 89bio Inc (ETNB) Be in Your Portfolio Thursday?  InvestorsObserver
  
  Read more

• Is Revance Therapeutics Inc (RVNC) Stock at the Top of the Biotechnology Industry? - InvestorsObserver

  11-05-2023 21:25 via news.google.com
  Is Revance Therapeutics Inc (RVNC) Stock at the Top of the Biotechnology Industry?  InvestorsObserver
  
  Read more

• Is Vericel Corp (VCEL) a Bad Choice in Biotechnology Thursday? - InvestorsObserver

  11-05-2023 21:20 via news.google.com
  Is Vericel Corp (VCEL) a Bad Choice in Biotechnology Thursday?  InvestorsObserver
  
  Read more

• Is Arcturus Therapeutics Holdings Inc (ARCT) a Good Choice in Biotechnology Thursday? - InvestorsObserver

  11-05-2023 18:51 via news.google.com
  Is Arcturus Therapeutics Holdings Inc (ARCT) a Good Choice in Biotechnology Thursday?  InvestorsObserver
  
  Read more

• Advertisement

• Recursion Pharmaceuticals: Pioneering Biotechnology for Better ... - Best Stocks

  11-05-2023 18:26 via news.google.com
  
  Recursion Pharmaceuticals: Pioneering Biotechnology for Better ...  Best Stocks
  
  Read more

• HudsonAlpha Institute for Biotechnology wins $1 million NSF ... - EurekAlert

  11-05-2023 17:37 via news.google.com
  
  HudsonAlpha Institute for Biotechnology wins $1 million NSF ...  EurekAlert
  
  Read more

• Cape Town hosts meeting to discuss research into genetic ... - IOL

  11-05-2023 15:03 via news.google.com
  Cape Town hosts meeting to discuss research into genetic ...  IOL
  
  Read more

• FDA, NIST to provide key tool for animal biotechnology developers - National Hog Farmer

  11-05-2023 14:31 via news.google.com
  
  FDA, NIST to provide key tool for animal biotechnology developers  National Hog Farmer
  
  Read more

• Advertisement

• Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTI - Yahoo Finance

  11-05-2023 14:30 via news.google.com
  Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTI  Yahoo Finance
  
  Read more

• ADNOC, LanzaTech Enter Strategic Partnership to Explore ... - waste360

  11-05-2023 13:04 via news.google.com
  
  ADNOC, LanzaTech Enter Strategic Partnership to Explore ...  waste360
  
  Read more

• Alexander Lyons Solutions continues growth trajectory with new ... - Onrec

  11-05-2023 09:47 via news.google.com
  
  Alexander Lyons Solutions continues growth trajectory with new ...  Onrec
  
  Read more

• Biotechnology Market Opportunities, Top Key Players, Target ... - Cottonwood Holladay Journal

  11-05-2023 02:28 via news.google.com
  
  Biotechnology Market Opportunities, Top Key Players, Target ...  Cottonwood Holladay Journal
  
  Read more

• ARIS MINING REPORTS Q1 2023 FINANCIAL AND OPERATING HIGHLIGHTS

  11-05-2023 02:21
  
  VANCOUVER, BC, May 10, 2023 /PRNewswire/ - Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS) (OTCQX: TPRFF) announces financial and operating results for the three months ended March 31, 2023 (Q1 2023). All amounts are in US dollars unless otherwise indicated. Aris Mining...
  
  Read more

• SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX

  11-05-2023 02:20
  
  NEW YORK, May 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Foghorn Therapeutics Inc. ("Foghorn" or the "Company") (NASDAQ: FHTX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
  
  Read more

• SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allbirds, Inc. - BIRD

  11-05-2023 02:20
  
  NEW YORK, May 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Allbirds, Inc. ("Allbirds" or the "Company") (NASDAQ: BIRD). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
  
  Read more

• SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LivePerson, Inc. - LPSN

  11-05-2023 02:15
  
  NEW YORK, May 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LivePerson, Inc. ("LivePerson" or the "Company") (NASDAQ: LPSN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
  
  Read more

• SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of JinkoSolar Holding Co., Ltd. - JKS

  11-05-2023 02:15
  
  NEW YORK, May 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
  
  Read more

• SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO

  11-05-2023 02:15
  
  NEW YORK, May 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alvotech ("Alvotech" or the "Company") (NASDAQ: ALVO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation...
  
  Read more

• Ethyl Chloride Global Market Report 2023: Sector Expected to Maintain an Impressive CAGR in the Forecast Period on Account of the Widespread Use of Pesticides

  11-05-2023 02:15
  
  DUBLIN, May 10, 2023 /PRNewswire/ -- The "Ethyl Chloride Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Product (Ethylene Chloride, Ethylene Dichloride), By Application (Pesticides, Dyes, Foam Plastics, Pharmaceuticals, Others), By Region...
  
  Read more

• Addictions Therapeutics market size to grow by USD 9.86 billion from 2022 to 2027; Growth driven by high consumption of alcohol, tobacco, and opioid products - Technavio

  11-05-2023 02:15
  
  NEW YORK, May 10, 2023 /PRNewswire/ -- The addictions therapeutics market size is set to grow by USD 9.86 billion from 2022 to 2027 progressing at a CAGR of 7.65% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest...
  
  Read more

• SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Virtu Financial, Inc. - VIRT

  11-05-2023 02:10
  
  NEW YORK, May 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Virtu Financial, Inc. ("Virtu" or the "Company") (NASDAQ: VIRT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
  
  Read more

• SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Coinbase Global, Inc. - COIN

  11-05-2023 02:10
  
  NEW YORK, May 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Coinbase Global, Inc. ("Coinbase" or the "Company") (NASDAQ: COIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
  
  Read more

• Japanese Artist Takes Message of Peace to G7 Gathering: Award-winning singer-song writer and Japan's first ever advocate artist launches peace education project

  11-05-2023 02:07
  
  Renowned artist, Ai, to perform first of its kind anthem for peace live in Hiroshima alongside students from around the world TOKYO, May 10, 2023 /PRNewswire/ -- In collaboration with the Japan Committee for UNICEF (UNICEF Japan), Japan's award-winning singer-songwriter, Ai (meaning love...
  
  Read more

• SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Loyalty Ventures, Inc. - LYLTQ

  11-05-2023 02:05
  
  NEW YORK, May 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Loyalty Ventures, Inc. ("Loyalty Ventures" or the "Company") (OTCMKTS: LYLTQ). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
  
  Read more

• SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arqit Quantum, Inc. (ARQQ) (f/k/a Centricus Acquisition Corp.)

  11-05-2023 02:05
  
  NEW YORK, May 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arqit Quantum, Inc. f/k/a Centricus Acquisition Corp. ("Arqit" or the "Company") (NASDAQ: ARQQ). Such investors are advised to contact Robert S. Willoughby at [email protected] or...
  
  Read more

• Anchor Health Properties Executes on Significant Atlanta Area Off Market Transaction of a 40,000 Square Foot MOB & Announces Phase II 40,000 Square Foot MOB Development

  11-05-2023 02:05
  
  ATLANTA, May 10, 2023 /PRNewswire/ -- Among the largest, non-health system owners of medical office buildings in the Atlanta MSA, Anchor Health Properties (Anchor), a national, full service healthcare real estate development, management, and investment company focused exclusively on...
  
  Read more

Follow @BiotechnologyUK on Twitter!